
Medical Affairs isn't a downstream function—it's the throughline connecting science, story, and strategy from development through commercialization. This episode features Howard Rutman, MD, MBA, Chief Medical Officer at Xalud Therapeutics and Peg Crowley-Nowick, PhD, MBA discussing the critical role of early Medical Affairs engagement. Key topics include how early Medical Affairs involvement speeds patient enrollment and data generation, qualities to seek in the first Medical Affairs hire, the value a lean team can bring to BioTech, and the importance of evidence plans that support physician and market access needs. The podcast emphasizes Medical Affairs as a continuous link from development to commercialization.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

One Size Does Not Fit All: Leading Medical Affairs Across a Diverse Portfolio

Proactive vs. Reactive: How the SIUU Guidance is Reshaping Medical Affairs Strategy with Josh Bryson

The Launch Starts Now: A CMO's Approach to Early Medical Affairs Strategy in Biotech with Nick Sarlis, MD, PhD, FACP

Medical Affairs as a Strategic Engine: De-Risking Biotech Development and Driving Commercial Success
Free AI-powered recaps of Medical Affairs Unscripted and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.